AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionDavy Global Fund Management Ltd
Latest Disclosed Ownership3,743 shares
Latest Disclosed Value $ 814,065
Davy Global Fund Management Ltd ownership in 4AB / AbbVie Inc.

On May 11, 2026 - Davy Global Fund Management Ltd filed a 13F-HR form disclosing ownership of 3,743 shares of AbbVie Inc. (DE:4AB) valued at $693,952 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 3,743 shares of AbbVie Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $705,556 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ABBVIE COM 00287Y109 3,743 0 0.00 814 -4.80 0.0618
2026-02-12 2025-12-31 13F ABBVIE COM 00287Y109 3,743 0 0.00 855 -1.27 0.0590
2025-11-05 2025-09-30 13F ABBVIE COM 00287Y109 3,743 -135 -3.48 867 20.45 0.0587
2025-08-01 2025-06-30 13F ABBVIE COM 00287Y109 3,878 0 0.00 720 -11.45 0.0640
2025-05-09 2025-03-31 13F ABBVIE COM 00287Y109 3,878 -1,236 -24.17 813 -10.57 0.0956
2025-02-12 2024-12-31 13F ABBVIE COM 00287Y109 5,114 -62 -1.20 909 -11.15 0.1073
2024-10-16 2024-09-30 13F ABBVIE COM 00287Y109 5,176 -160 -3.00 1,022 11.69 0.1064
2024-07-29 2024-06-30 13F ABBVIE COM 00287Y109 5,336 -103 -1.89 915 -7.58 0.1048
2024-05-01 2024-03-31 13F ABBVIE COM 00287Y109 5,439 1,232 29.28 990 52.07 0.1122
2024-02-09 2023-12-31 13F ABBVIE COM 00287Y109 4,207 -6,225 -59.67 652 -58.11 0.0768
2023-10-18 2023-09-30 13F ABBVIE COM 00287Y109 10,432 -1,816 -14.83 1,555 -5.82 0.3193
2023-07-25 2023-06-30 13F ABBVIE COM 00287Y109 12,248 0 0.00 1,650 -15.43 0.3134
2023-05-10 2023-03-31 13F ABBVIE COM 00287Y109 12,248 -1,271 -9.40 1,952 -10.67 0.3743
2023-02-08 2022-12-31 13F ABBVIE COM 00287Y109 13,519 380 2.89 2,185 23.88 0.4480
2022-10-26 2022-09-30 13F ABBVIE COM 00287Y109 13,139 -1,554 -10.58 1,763 -21.64 0.3961
2022-08-03 2022-06-30 13F ABBVIE COM 00287Y109 14,693 312 2.17 2,250 -3.47 0.4454
2022-04-28 2022-03-31 13F ABBVIE COM 00287Y109 14,381 -4,239 -22.77 2,331 -7.54 0.3802
2022-02-02 2021-12-31 13F ABBVIE COM 00287Y109 18,620 -3,646 -16.37 2,521 4.95 0.3865
2021-10-27 2021-09-30 13F ABBVIE COM 00287Y109 22,266 -5,701 -20.38 2,402 -23.75 0.3665
2021-07-19 2021-06-30 13F ABBVIE COM 00287Y109 27,967 4,122 17.29 3,150 22.05 0.4822
2021-05-11 2021-03-31 13F ABBVIE COM 00287Y109 23,845 11,182 88.30 2,581 90.20 0.4544
2021-01-29 2020-12-31 13F ABBVIE COM 00287Y109 12,663 454 3.72 1,357 26.94 0.3140
2020-10-22 2020-09-30 13F ABBVIE COM 00287Y109 12,209 394 3.33 1,069 -7.84 0.3200
2020-07-22 2020-06-30 13F ABBVIE COM 00287Y109 11,815 -206 -1.71 1,160 26.64 0.3901
2020-05-05 2020-03-31 13F ABBVIE COM 00287Y109 12,021 243 2.06 916 -12.18 0.3750
2020-02-06 2019-12-31 13F ABBVIE COM 00287Y109 11,778 -1,103 -8.56 1,043 6.97 0.3302
2019-11-13 2019-09-30 13F ABBVIE COM 00287Y109 12,881 0 0.00 975 4.17 0.3157
2019-07-19 2019-06-30 13F ABBVIE COM 00287Y109 12,881 2,585 25.11 936 -1.37 0.3022
2019-02-13 2018-12-31 13F ABBVIE COM 00287Y109 10,296 0 0.00 949 -5.19 0.3476
2018-11-14 2018-09-30 13F ABBVIE COM 00287Y109 10,296 350 3.52 1,001 8.69 0.2747
2018-08-15 2018-06-30 13F/A-1 ABBVIE COM 00287Y109 9,946 -961 -8.81 921 16.43 0.2467
2018-08-14 2018-06-30 13F ABBVIE COM 00287Y109 9,946 -961 345
2017-05-15 2017-03-31 13F ABBVIE COM 00287Y109 10,907 0 0.00 791 2.59 0.1485
2017-02-14 2016-12-31 13F ABBVIE COM 00287Y109 10,907 -309 -2.75 771 2.66 0.1400
2016-11-14 2016-09-30 13F ABBVIE COM 00287Y109 11,216 -75 -0.66 751 0.54 0.1388
2016-08-02 2016-06-30 13F ABBVIE COM 00287Y109 11,291 -21,930 -66.01 747 -63.31 0.1406
2016-05-09 2016-03-31 13F ABBVIE COM 00287Y109 33,221 -113 -0.34 2,036 -8.00 0.3719
2016-02-05 2015-12-31 13F ABBVIE COM 00287Y109 33,334 -2,078 -5.87 2,213 5.13 0.3794
2015-11-05 2015-09-30 13F ABBVIE COM 00287Y109 35,412 -1,876 -5.03 2,105 -23.20 0.3401
2015-08-13 2015-06-30 13F ABBVIE COM 00287Y109 37,288 -8,905 -19.28 2,741 -10.40 0.3947
2015-05-15 2015-03-31 13F/A-1 ABBVIE COM 00287Y109 46,193 -5,056 -9.87 3,059 -9.76 0.4096
2015-05-15 2015-03-31 13F ABBVIE COM 00287Y109 46,193 3,059
2015-02-17 2014-12-31 13F ABBVIE COM 00287Y109 51,249 51,249 3,390 0.4911
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.